Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
6 trials match this view; 14 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 250 across 6 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Countries with reported trial locations
Sponsors recorded in this index
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite TrialAdvanced Cancer · Demoralization · Existential Distress · Psychological Distress | University of Calgary PHASE2 | Not yet recruiting Registry updated 2026-09-02 | 60 ESTIMATED | 2026-10-30 2027-12-20 2027-12-31 | |
| Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)Palliative Care · Pain · Anxiety · Depression · Demoralization · Psychological Distress · Quality of Life · Caregiver Burden · Fear of Death · Existential Distress | University Hospital, Basel, Switzerland PHASE2 | Recruiting Registry updated 2026-04-29 | 60 ESTIMATED | 2024-06-09 2027-09 2028-05 | |
| Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot StudyDemoralization · Safety | Gustavo Vazquez PHASE1 | Recruiting Registry updated 2026-03-18 | 15 ESTIMATED | 2026-04-01 2027-06-01 2027-06-01 | |
| Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional HealthDemoralization | University of Alabama at Birmingham EARLY_PHASE1 | Withdrawn Registry updated 2026-03-11 | 0 ACTUAL | 2023-08-15 2026-03 2026-03 | |
| Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH StudyHospice · Psilocybin · Demoralization · Terminal Illness · Cancer-related Problem/Condition · Psychotherapy · Terminal Cancer · Cancer Terminal | Yvan Beaussant, MD, MSci PHASE2 | Completed Registry updated 2026-02-17 | 15 ACTUAL | 2022-03-09 2024-07-27 2025-12-31 | |
| Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of LifeDemoralization | Charles S. Grob, M.D. PHASE2 | Recruiting Registry updated 2025-11-25 | 100 ESTIMATED | 2025-01-19 2026-12-31 2027-12-31 |
Reported research facilities
Arthur Child Comprehensive Cancer CentreCalgary, Alberta, Canada
Providence Care HospitalKingston, Ontario, Canada
University Hospital Basel, Division of Clinical Pharmacology and ToxicologyBasel, Switzerland
University Hospital Geneva, Palliative medicine departmentCollonge-Bellerive, Switzerland
Spital Uster AG, Division of Internal MedicineUster, Switzerland
University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative CareZurich, Switzerland
Queen's UniversityKingston, Ontario, Canada
University of Alabama at BirminghamBirmingham, Alabama, United States
Care DimensionsDanvers, Massachusetts, United States
Marin Cancer CareGreenbrae, California, United States
University of California, Los AngelesLos Angeles, California, United States
University of San FranciscoSan Francisco, California, United States
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterTorrance, California, United States
Sunstone TherapiesRockville, Maryland, United States
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.